Jeffrey M. Leiden, Executive Chairman at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 19,816 shares at $349.48 ($6.9M) on 2023-05-02, disclosed to the SEC on 2023-05-04.
Scheduled sale ($6.9M) by Executive Chairman under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $349.48 | 4,645 | $1.6M | 23.4% |
| 2 | $349.48 | 4,645 | $1.6M | 23.4% |
| 3 | $350.48 | 1,505 | $527K | 7.6% |
| 4 | $350.48 | 1,505 | $527K | 7.6% |
| 5 | $353.18 | 300 | $106K | 1.5% |
| 6 | $349.22 | 2,008 |
| $701K |
| 10.1% |
| 7 | $349.22 | 2,008 | $701K | 10.1% |
| 8 | $350.53 | 1,800 | $631K | 9.1% |
| 9 | $351.59 | 700 | $246K | 3.5% |
| 10 | $351.59 | 700 | $246K | 3.5% |
| Total | $349.88 avg | 19,816 | $6.9M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |